As noted above, severe falciparum malaria is associated with low NO bioavailability [87], [88], and a polymorphism in the nitric oxide synthase 2 (NOS2) promoter—which increases NO production and is prevalent in Kenyan and Tanzanian children—was associated with substantial protection from severe malaria [89]. The gene discussed is NOS2; the disease is malaria.